Form 4: Renovaro Inc. Director James Sapirstein Acquires Options
SEC Form 4 Filing
Director James Sapirstein reports acquisition of options to purchase 28,196 shares of Renovaro Inc. common stock.
Summary
- On March 19, 2024, James Sapirstein, a director of Renovaro Inc. (RENB), filed a Form 4 with the SEC.
- The report details a transaction on March 6, 2024, where Sapirstein acquired options to purchase 28,196 shares of common stock at an exercise price of $2.66.
- These options are exercisable from March 6, 2025, and expire on March 6, 2034.
- Following the transaction, Sapirstein directly owns 28,196 derivative securities.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports a transaction. It doesn't inherently indicate positive or negative outlook.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, trade in their company's stock. This filing indicates changes in Sapirstein's holdings of Renovaro Inc. securities.
Stakeholder Impact
- The acquisition of options by a director could be viewed positively by shareholders as it aligns the director's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 03/06/2024 | Date of transaction: Acquisition of options. |
| 03/06/2025 | Options become exercisable. |
| 03/06/2034 | Options expiration date. |
| 03/19/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.